Warning letters, 483s, Recalls, Import Alerts, Audit observations
The U.S. FDA issued a warning letter to International Laboratories Corp. (FEI 3006403166) following CGMP
Indian API manufacturer Jagsonpal Pharmaceuticals was issued a Warning Letter by the US FDA in
Everest Organics Ltd (Telangana, India) was issued a GMP Non-Compliance Report with recommendation to suspend
USFDA 483 / UCB Farchim SA/ June 2023 / Gaps in Data Integrity program, lack
Related Links Warning letter Intas Warning letter Centaur Warning letter Medgel Warning letter Baxter Intas
FDA published the USFDA483 issued to Intas site (FEI 3003157498) in Ahmedabad, India after inspection
USFDA Inspected IPCA (Ratlam, India) site in June 2023, Inspectors – Rajiv R Srivastava, Salim
IPCA Ratlam (India) was issued USFDA 483 with 11 observations after inspection in June 2023
